Amarantus Bioscience Holdings Inc (AMBS)

[Solantey]

"Big pharma" development partnership or buyout in 2013.

Major drug companies are flush with cash and facing the "patent cliff" for many of their major revenue producing drugs.

$1.00 price target.

"2013 Stock of the Year" and "2013 Bio-Tech C.E.O. of the Year" are right in front of you.

A very "Merry Christmas" and a very, very, prosperous 2013 for the shareholders.


p.s. This is setting up for a major short squeeze.